Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Treating chronic occlusive arterial disease].

M Rottman1, J Koepchen, B Angelkort

  • 1Medizinische Klinik Nord-Angiologie/Diabetologie, Klinikum Dortmund gGmbH. marcusrottmann@t-online.de

MMW Fortschritte Der Medizin
|June 7, 2005
PubMed
Summary

Managing cardiovascular risk factors is key for treating chronic occlusive arterial disease. All symptomatic patients with peripheral arterial occlusive disease (POAD) should receive antiplatelet therapy to prevent progression and manage symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hip Joint Infections Caused by Multidrug-Resistant Enterobacterales Among Patients With Spinal Cord Injury: Experience of a Reference Center in the Greater Paris Area.

Open forum infectious diseases·2022
Same author

Native bone and joint infections caused by extended-spectrum β-lactamase-producing Enterobacterales: experience of a reference centre in the Greater Paris area.

International journal of antimicrobial agents·2021
Same author

Case series of carbapenemase-producing Enterobacteriaceae osteomyelitis: Feel it in your bones.

Journal of global antimicrobial resistance·2020
Same author

[Clinical presentation and performance of urine dipstick for diagnosis of urinary infection in geriatric population].

La Revue de medecine interne·2019
Same author

Management of established pressure ulcer infections in spinal cord injury patients.

Medecine et maladies infectieuses·2018
Same author

Rapid Isolation of Staphylococcus aureus Pathogens from Infected Clinical Samples Using Magnetic Beads Coated with Fc-Mannose Binding Lectin.

PloS one·2016

Area of Science:

  • Vascular Medicine
  • Cardiovascular Surgery
  • Preventive Cardiology

Background:

  • Chronic occlusive arterial disease management focuses on secondary prevention.
  • Cardiovascular risk factor management is the cornerstone of treatment across all disease stages.

Purpose of the Study:

  • To outline the treatment strategy for peripheral arterial occlusive disease (POAD) based on disease stage.
  • To emphasize the role of antiplatelet therapy and risk factor modification.

Main Methods:

  • Review of current treatment guidelines for POAD.
  • Staging of POAD based on clinical presentation and progression.
  • Consideration of interventional and surgical options based on lesion morphology.

Main Results:

Related Experiment Videos

  • Stage I POAD: focus on preventing progression.
  • Stage II POAD: risk factor management, antiplatelet agents, and potential for walking programs or revascularization.
  • Advanced stages: revascularization decisions based on morphology and comorbidities; PGE1 for unreconstructable cases; amputation as a last resort.

Conclusions:

  • Comprehensive management of cardiovascular risk factors is essential for all POAD stages.
  • Antiplatelet therapy is indicated for symptomatic POAD patients without contraindications.
  • Treatment decisions, including revascularization or amputation, must be individualized based on disease severity, morphology, and patient factors.